HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Germline EPHB2 receptor variants in familial colorectal cancer.

Abstract
Familial clustering of colorectal cancer occurs in 15-20% of cases, however recognized cancer syndromes explain only a small fraction of this disease. Thus, the genetic basis for the majority of hereditary colorectal cancer remains unknown. EPHB2 has recently been implicated as a candidate tumor suppressor gene in colorectal cancer. The aim of this study was to evaluate the contribution of EPHB2 to hereditary colorectal cancer. We screened for germline EPHB2 sequence variants in 116 population-based familial colorectal cancer cases by DNA sequencing. We then estimated the population frequencies and characterized the biological activities of the EPHB2 variants identified. Three novel nonsynonymous missense alterations were detected. Two of these variants (A438T and G787R) result in significant residue changes, while the third leads to a conservative substitution in the carboxy-terminal SAM domain (V945I). The former two variants were found once in the 116 cases, while the V945I variant was present in 2 cases. Genotyping of additional patients with colorectal cancer and control subjects revealed that A438T and G787R represent rare EPHB2 alleles. In vitro functional studies show that the G787R substitution, located in the kinase domain, causes impaired receptor kinase activity and is therefore pathogenic, whereas the A438T variant retains its receptor function and likely represents a neutral polymorphism. Tumor tissue from the G787R variant case manifested loss of heterozygosity, with loss of the wild-type allele, supporting a tumor suppressor role for EPHB2 in rare colorectal cancer cases. Rare germline EPHB2 variants may contribute to a small fraction of hereditary colorectal cancer.
AuthorsGeorge Zogopoulos, Claus Jorgensen, Julinor Bacani, Alexandre Montpetit, Pierre Lepage, Vincent Ferretti, Lauren Chad, Subani Selvarajah, Brent Zanke, Thomas J Hudson, Tony Pawson, Steven Gallinger
JournalPloS one (PLoS One) Vol. 3 Issue 8 Pg. e2885 (Aug 06 2008) ISSN: 1932-6203 [Electronic] United States
PMID18682749 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
  • Receptor, EphB2
Topics
  • Adenomatous Polyposis Coli (genetics)
  • Base Sequence
  • Colorectal Neoplasms (genetics)
  • Colorectal Neoplasms, Hereditary Nonpolyposis (genetics)
  • DNA, Neoplasm (genetics, isolation & purification)
  • Exons
  • Female
  • Genetic Variation
  • Germ-Line Mutation
  • Humans
  • Male
  • Pedigree
  • Polymorphism, Single Nucleotide
  • Receptor, EphB2 (genetics)
  • Reference Values
  • Registries

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: